Latest Resources

ACB’s Statement on the Xenophobic Violence in South Africa

As an organisation that works with multiple partners across the African continent for ecological and social transformation of food systems in favour of small farmers and the poor, the African Centre for Biodiversity (ACB) is deeply disturbed and outraged by the outbreaks of violence against our sisters and brothers in South Africa. At a time […]

ACB’s Commentary on An Africa-Europe Agenda for Rural Transformation: Report by the Task Force Ru...

The European Union (EU) is in the process of defining a new set of priorities in the African agricultural and food sectors, through the proposed implementation of the EU-Africa Alliance for Sustainable Investment and Jobs. Their Task Force for Rural Africa published a report with draft recommendations, which is oriented towards promoting the capitalist transformation […]

ACB’s Objection to Monsanto’s Application for Commodity Import of GM maize for a number of events...

ACB’s Objection to Monsanto’s Application for Commodity Import of GM maize for a number of events: herbicide tolerance, including for dicamba, as well as pest resistance – MON 87427 x MON 89034 x MIR 162 x MON87419; MON 87427 x MON 89034 x MON810 x MIR 162 x MON 87411 x MON 87419; and MON […]

Objection against general release of three 2,4-D GM maize varieties

Objection against general release of three 2,4-D GM maize varieties: 1. Corteva’s 2,4-D herbicide tolerant maize: DAS-40278-9 2. Corteva’s Stacked 2,4-D and glyphosate herbicide tolerant maize: NK603 x DAS-40278-9 3. Corteva’s Stacked 2,4-D, glyphosate and glufosinate herbicide tolerant, and Bt insecticidal maize: MON89034 x TC1507 x NK603 x DAS-40278-9 The objection is in relation to […]

Objection to Application by Dow for general release of GM maize: MON89034 X TC1507 x NK603 with t...

The ACB has played an essential watch-dog role on new GMO permits in South Africa for a decade now, adding substantially to the discourse about the scientific assessment of GMOs as well as about issues of socioeconomic impacts and democratic decisionmaking, through lodging substantive comments on at least 30 permit applications. We are objecting to […]

ACB’s Objection to Monsanto’s Application for Commodity Clearance of MON 87708 × MON 89788 × A554...

ACB is objecting to the commodity clearance of the triple-stacked GM soybean event MON 87708 x MON 89788 x A5547-127, due to concerns surrounding the lack of safety assessment data for this crop and the known toxicity of the three pesticides it is designed to tolerate. Its tolerance to three pesticides, glyphosate, glufosinate and dicamba […]

Comments on the Competition Amendment Bill 2017

ACB has responded to the Economic Development Department (EDD) call for comments on the Competition Amendment Bill 2017. The amendments aim to strengthen the powers of the competition authorities to proactively investigate and develop remedies to deconcentrate markets. Although we do not agree with EDD’s entire approach to concentration (for example, that concentration and economies […]

MVIWATA and ACB Opposing Application for Field trials of Stacked GM Maize MON 87460 X MON 810

The Tanzania National Farmers Network Organisation, Mtandao wa Vikundi vya Wakulima Tanzania (MVIWATA) and the African Centre for Biodiversity (ACB) are objecting to an application submitted by the Tanzania Commission for Science and Technology (COSTECH) for confined field trials of Monsanto’s stacked GM maize MON 87460 X MON 810 (GM drought tolerant stacked with throw-away […]

Lobbying papers on South Africa’s Plant Improvement Bill and Plant Breeders’ Rights Bill

Commentary on South Africa’s Plant Improvement Bill and Plant Breeders’ Rights Bill. Read here.

Objection to commercial release of MON87460 X NK603 X MON89034 (triple stacked involving drought ...

In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event. Drought tolerance is a highly complex genetic trait that cannot be addressed by single gene insertions, as shown by the lack of data backing up the applicant’s claim that this GM variety shows “improvements […]